| The impact of brand equity on brand preference and purchase intentions in the service industries HH Chang, YM Liu The Service Industries Journal 29 (12), 1687-1706, 2009 | 779 | 2009 |
| Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan YM Liu, YHK Yang, CR Hsieh Journal of health economics 28 (2), 341-349, 2009 | 170 | 2009 |
| Effect of air pollution on health care expenditure: Evidence from respiratory diseases YM Liu, CK Ao Health Economics 30 (4), 858-875, 2021 | 39 | 2021 |
| Regulation and competition in the Taiwanese pharmaceutical market under national health insurance YM Liu, YHK Yang, CR Hsieh Journal of health economics 31 (3), 471-483, 2012 | 34 | 2012 |
| The determinants of the adoption of pharmaceutical innovation: evidence from Taiwan YM Liu, YHK Yang, CR Hsieh Social science & medicine 72 (6), 919-927, 2011 | 30 | 2011 |
| Recent trends in utilization of antidiabetic medications from 2008-2013: a nation-wide population-based study from Taiwan WJS Ou HT, Chang KC, Liu YM Journal of Diabetes 9, 256-266, 2017 | 28* | 2017 |
| New drugs and the growth of health expenditure: evidence from diabetic patients in Taiwan YM Liu, CR Hsieh Health Economics 21 (5), 496-513, 2012 | 16 | 2012 |
| Population aging, technological innovation, and the growth of health expenditure: Evidence from patients with Type 2 diabetes in Taiwan YM Liu Value in health regional issues 21, 120-126, 2020 | 13 | 2020 |
| Exploring the relationship between nursing hours per patient day and mortality rate of hospitalised patients in Taiwan YC Chang, M Yen, SM Chang, YM Liu Journal of Nursing Management 25 (2), 85-92, 2017 | 12 | 2017 |
| Comparative cost-effectiveness of metformin-based dual therapies associated with risk of cardiovascular diseases among Chinese patients with type 2 diabetes: Evidence from a … HT Ou, YT Chen, YM Liu, JS Wu Diabetes Research and Clinical Practice 116, 14-25, 2016 | 12 | 2016 |
| Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan YM Liu International health 12 (4), 272-280, 2020 | 9 | 2020 |
| Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan CR Hsieh, YM Liu, CL Chang The European Journal of Health Economics 14, 287-295, 2013 | 8 | 2013 |
| The effect of competition on the practice of outpatient services for diabetes patients at different levels of hospitals in Taiwan YM Liu*, J Kinsey Applied Economics 37 (12), 1411-1422, 2005 | 8 | 2005 |
| Availability, health-care costs, and utilization patterns of biologics in Taiwan CR Hsieh, YM Liu Value in Health 15 (1), S35-S42, 2012 | 7 | 2012 |
| Hospital competition and prescribing behaviors: empirical evidence from taiwan YM Liu, YHK Yang, HT Ou The Journal of Developing Areas, 125-141, 2010 | 7 | 2010 |
| Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan YM Liu, HT Ou, YK Yang J Ment Health Policy Econ 17 (4), 163-172, 2014 | 5 | 2014 |
| Determinants of generic entry in the regulated Taiwanese prescription drug market YM Liu, JS Cheng Health policy 108 (2-3), 228-235, 2012 | 5 | 2012 |
| Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market: evidence from Taiwan YM Liu, CR Hsieh The BE Journal of Economic Analysis & Policy 14 (1), 241-275, 2014 | 3 | 2014 |
| Revisiting the pharmaceutical price gap YM Liu Taiwan Journal of Public Health 39 (1), 64-73, 2020 | | 2020 |
| An empirical analysis of exits from the hospital market YM Liu, TF Lo, YT Nien Taiwan Journal of Public Health 36 (3), 273-286, 2017 | | 2017 |
